Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 27;13:860161. doi: 10.3389/fgene.2022.860161

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Li, Chen, Luo, Wang, Yu, Gao and Zhong.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The potential prognostic value of CD38 and CXCL13 in OC patients with immunotherapy. (A) tSNE plot of various cell types in the GSE115978 cohort; (B,C) The expression of CD38 in multiple cells; (D,E) The expression of CXCL13 in multiple cells; Kaplan-Meier curves showed the prognosis of (F) CD38 and (G) CXCL13 in the IMvigor210 cohort; The violin plots showed the difference of (H) CD38 and (I) CXCL13 expression in the CR/PR and SD/PD groups. CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.